Agenda

06/02/2026

Recent Advances in Genitourinary Malignancies (RAGM-2026) - 6 February 2026 - FREE REGISTRATION OPEN!

Auditori PRBB at 8:30 am

On 6 February 2026 will take place a new edition of the "Recent Advances in Genitourinary Malignancies (RAGM-2026)" symposium, organized by the Hospital del Mar Research Institute and directed by Dr. Joaquim Bellmunt, Group leader of the urological cancer research group and Dr. Juan Pablo Fusco Head of the Department of Medical Oncology Quironsalud.

For more information and free registration please access to: RAGM Symposium 2026

The program is as follows:

08:30 - 09:45 Registration

08:45 - 09:00 Welcome and Opening. Dr. Joan Albanell

09:00 - 10:10 Round Table 1: Prostatic Cancer.

Moderator: Dr. Lluis Fumadó Ciutat

09:00 - 09:05 Presentation

09:05 - 09:20 Treatment strategies for first line hormone sensitive prostate cancer. Dr. Jose Luis Pérez Gracia

09:20 - 09:35 Expert opinion: The emerging role of parp inhibitors in combination in prostate cancer Optimal therapeutic sequence in mCRPC. Dr. Karim Fizazi

09:35 - 09:50 Novel Targets and Therapeutic Strategies. Dr. J. M Piulats

09:50 - 10:10 Discussion

10:10 - 11:50 Round Table 2: Bladder Cancer

Moderator: Dr. Joaquim Bellmunt

10:10 - 10:15 Presentation

10:15 - 10:30 New treatment options in BCG naïve and refractory NMIBC. Dr. Félix Guerrero Ramos

10:30 - 10:45 New approaches in perioperative Muscle invasive Bladder Cancer. Dr. Begoña Pérez Valderrama

10:45 - 11:15 Controversies first Line options in Metastatic Bladder Cancer: What is next? Dr. Álvaro Pinto(PRO) & Dr. Mª José Juan Fita (CON)

11:15 - 11:30 ct-DNA in urological malignancies. Dr. Thomas Powles.

11:30 - 12:00 Discussion

12:00 - 12:30 Coffee break

12:30 - 14:00 Round Table 3: Kidney Cancer

Moderator: Dr. Juan Pablo Fusco

12:30 - 12:35 Presentation

12:35 - 12:50 Adjuvant therapy in real cell carcinoma. Dr. Jose Pablo Maroto

12:50 - 13:05 Relevant aspects to select the best sequence in first line including HIF2alfa inhibitors. Dr. Daniel Sentana

13:05 - 13:20 Managementofvarianthistologies inRCC. New treatment options Dr. Javier Puente

13:20 - 14:00 Discussion

14:00 - 14:20 Keynote lecture: Ongoing clinical studies in prostate cancer. Dr. Neraj Agarwall.

14:20 - 14:30 Closing remarks Dr. Joaquim Bellmunt & Dr. Juan Pablo Fusco

Download the program

__________________________________________________

Contact
Meeting Pharma, A/A Marina Rodríguez
[email protected]

Tots els actes